SEC Form 4

FORM 4		UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5
 Â	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person* OEP VII GP, L.L.C. (Last) (First) (Middle) C/O ONE EQUITY PARTNERS 510 MADISON AVENUE, 19TH FLOOR (Street) NEW YORK NY 10022 (City) (State) (Zip)	2. Issuer Name and Ticker or Trading Symbol AdaptHealth Corp. [ AHCO ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director X 10% Owner Officer (give title below) Other (specify below)
	3. Date of Earliest Transaction (Month/Day/Year) 09/11/2020
	4. If Amendment, Date of Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable Line) Form filed by One Reporting Person X Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	09/11/2020		C(3)		2,887,709(3)	A(3)	(3)	13,818,180(1)(2)(3)	I	See footnotes(1)(2)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Series A Convertible Preferred Stock	$13.75(4)	09/11/2020		C(3)			39,706	(4)	(4)	Class A Common Stock	2,887,709(3)(4)	(3)(4)	0(3)(4)	I	See footnotes(1)(2)

1. Name and Address of Reporting Person* OEP VII GP, L.L.C. (Last) (First) (Middle) C/O ONE EQUITY PARTNERS 510 MADISON AVENUE, 19TH FLOOR (Street) NEW YORK NY 10022 (City) (State) (Zip)

1. Name and Address of Reporting Person* OEP AHCO Investment Holdings, LLC (Last) (First) (Middle) C/O ONE EQUITY PARTNERS 510 MADISON AVENUE, 19TH FLOOR (Street) NEW YORK NY 10022 (City) (State) (Zip)

1. Name and Address of Reporting Person* ONE EQUITY PARTNERS VII, L.P. (Last) (First) (Middle) C/O ONE EQUITY PARTNERS 510 MADISON AVENUE, 19TH FLOOR (Street) NEW YORK NY 10022 (City) (State) (Zip)

1. Name and Address of Reporting Person* ONE EQUITY PARTNERS VII-A, L.P. (Last) (First) (Middle) C/O ONE EQUITY PARTNERS 510 MADISON AVENUE, 19TH FLOOR (Street) NEW YORK NY 10022 (City) (State) (Zip)

1. Name and Address of Reporting Person* ONE EQUITY PARTNERS VII-B, L.P. (Last) (First) (Middle) C/O ONE EQUITY PARTNERS 510 MADISON AVENUE, 19TH FLOOR (Street) NEW YORK NY 10022 (City) (State) (Zip)

1. Name and Address of Reporting Person* OEP VII Project A Co-Investment Partners, L.P. (Last) (First) (Middle) C/O ONE EQUITY PARTNERS 510 MADISON AVENUE, 19TH FLOOR (Street) NEW YORK NY 10022 (City) (State) (Zip)

1. Name and Address of Reporting Person* OEP VII PROJECT A-I CO-INVESTMENT PARTNERS, L.P. (Last) (First) (Middle) C/O ONE EQUITY PARTNERS 510 MADISON AVENUE, 19TH FLOOR (Street) NEW YORK NY 10022 (City) (State) (Zip)

1. Name and Address of Reporting Person* OEP VII General Partner, L.P. (Last) (First) (Middle) C/O ONE EQUITY PARTNERS 510 MADISON AVENUE, 19TH FLOOR (Street) NEW YORK NY 10022 (City) (State) (Zip)

1. Name and Address of Reporting Person* CASHIN RICHARD M JR (Last) (First) (Middle) C/O ONE EQUITY PARTNERS 510 MADISON AVENUE, 19TH FLOOR (Street) NEW YORK NY 10022 (City) (State) (Zip)

1. Name and Address of Reporting Person* Han David (Last) (First) (Middle) C/O ONE EQUITY PARTNERS 510 MADISON AVENUE, 19TH FLOOR (Street) NEW YORK NY 10022 (City) (State) (Zip)

Explanation of Responses:

1. These securities are held directly by OEP AHCO Investment Holdings, LLC ("Investor"). Investor is owned by One Equity Partners VII, L.P., a Cayman Islands exempted limited partnership ("OEP VII LP"), One Equity Partners VII-A, L.P., a Cayman Islands exempted limited partnership ("OEP VII-A LP"), One Equity Partners VII-B, L.P., a Delaware limited partnership ("OEP VII-B LP"), OEP VII Project A Co-Investment Partners, L.P., a Delaware limited partnership ("OEP VII Project A LP") and OEP VII Project A-I Co-Investment Partners, L.P., a Delaware limited partnership ("OEP VII Project A-I LP" and, together with OEP VII LP, OEP VII-A LP, OEP VII-B LP and OEP VII Project A LP, the "Parallel Funds"). The general partner of each of the Parallel Funds is OEP VII General Partner, L.P., a Cayman Islands exempted limited partnership ("OEP VII GP"), and the general partner of OEP VIIGP is OEP VII GP, L.L.C., a Cayman Islands limited liability company ("OEP VII GP LLC").

2. (Continued from Footnote 1) OEP VII GP LLC is member-managed by Messrs. Richard Cashin and David Han. By virtue of the relationships described above, each of the Parallel Funds, OEP VII GP, OEP VII GP LLC and Messrs. Richard Cashin and David Han may be deemed to beneficially own, and share voting and dispositive power with respect to, the securities held directly by Investor. Each of the reporting persons disclaims beneficial ownership of the securities except to the extent of its or his pecuniary interest therein.

3. The Reporting Persons are filing this Form 4 to report the conversion by the Issuer (as defined below) of 39,706 shares of Series A Preferred Stock (as defined below), resulting in the acquisition by the Reporting Persons of 2,887,709 shares of Class A Common Stock (as defined below).

4. The number of shares of Class A Common Stock of AdaptHealth Corp., a Delaware corporation (the "Issuer"), having par value of $0.0001 per share (the "Class A Common Stock"), deliverable upon conversion of each share of Series A Convertible Preferred Stock, par value $0.0001 per share (the "Series A Preferred Stock"), is equal to 72.727273 shares, subject to customary anti-dilution and other adjustments. The terms of the Series A Preferred Stock generally restrict the conversion of such shares until the shares of Class A Common Stock issuable upon conversion thereof has been approved by stockholders of the Issuer in accordance with Nasdaq Listing Rules. Such stockholder approval was obtained on August 27, 2020. The Series A Preferred Stock has no expiration date.

Remarks:

	OEP AHCO INVESTMENT HOLDINGS, LLC, By: /s/ Bradley J. Coppens, Authorized Person	09/11/2020
	ONE EQUITY PARTNERS VII, L.P., By: OEP VII General Partner, L.P., its general partner, By: OEP VII GP, L.L.C., its general partner, By: /s/ Gregory Belinfanti, Authorized Person	09/11/2020
	ONE EQUITY PARTNERS VII-A, L.P., By: OEP VII General Partner, L.P., its general partner, By: OEP VII GP, L.L.C., its general partner, By: /s/ Gregory Belinfanti, Authorized Person	09/11/2020
	ONE EQUITY PARTNERS VII-B, L.P., By: OEP VII General Partner, L.P., its general partner, By: OEP VII GP, L.L.C., its general partner, By: /s/ Gregory Belinfanti, Authorized Person	09/11/2020
	OEP VII PROJECT A CO-INVESTMENT PARTNERS, L.P., By: OEP VII General Partner, L.P., its general partner, By: OEP VII GP, L.L.C., its general partner, By: /s/ Gregory Belinfanti, Authorized Person	09/11/2020
	OEP VII PROJECT A-I CO-INVESTMENT PARTNERS, L.P., By: OEP VII General Partner, L.P., its general partner, By: OEP VII GP, L.L.C., its general partner, By: /s/ Gregory Belinfanti, Authorized Person	09/11/2020
	OEP VII GENERAL PARTNER, L.P., By: OEP VII GP, L.L.C., its general partner, By: /s/ Gregory Belinfanti, Authorized Person	09/11/2020
	OEP VII GP, L.L.C., By: /s/ Gregory Belinfanti, Authorized Person	09/11/2020
	/s/ Richard Cashin	09/11/2020
	/s/ David Han	09/11/2020
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.